"GlaxoSmithKline discovers, develops and manufactures pharmaceuticals, vaccines and consumer healthcare products." read more
Emma Walmsley GlaxoSmithKline CEO Rating
Emma Walmsley GlaxoSmithKline CEO Rating
GlaxoSmithKline's CEO, Emma Walmsley, has 30 employee ratings and a score of 58/100, placing them in the Bottom 20% of similar size companies on Comparably with 10,000+ Employees and Bottom 15% of other companies in New York.
Where This Score Ranks GlaxoSmithKline's CEO Rating
- BOTTOM20%
In the Bottom 20% of 1339 Similar Sized Companies on Comparably
- BOTTOM15%
In the Bottom 15% of 707 Nearby Companies in New York
- 5th
5th place versus 5 competitors rated on Comparably
52
Feb
53
Apr
54
May
59
Jun
57
Oct
D58 / 100
Jan
GlaxoSmithKline CEO Emma Walmsley Bio
Emma Walmsley serves as the CEO / President of GlaxoSmithKline.
Not Enough Ratings To Show Who Ranks CEO Rating the Highest
Anonymously rate my experience at GlaxoSmithKlineNot Enough Ratings To Show Who Ranks CEO Rating the Lowest
Anonymously rate my experience at GlaxoSmithKlineGlaxoSmithKline CEO Emma Walmsley At a Glance
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at GlaxoSmithKline.
Based on 30 ratings, Emma Walmsley ranks right below Bristol Myers Squibb's CEO, Giovanni Caforio.
Overall, the CEO score has remained stable over the last 90 days.
GlaxoSmithKline CEO Emma Walmsley Rating Trendline
- GlaxoSmithKline58
- Other Companies in New York
- Similar Size on Comparably
GlaxoSmithKline's CEO Rating Rank Against Similar Sized Companies on Comparably
BOTTOM
20%
GlaxoSmithKline ranks in the Bottom 20% of other companies on Comparably with 10,000+ Employees for CEO Rating Score.
GlaxoSmithKline's CEO Rating Rank Against Other Companies Nearby
BOTTOM
15%
GlaxoSmithKline ranks in the Bottom 15% of other companies in New York for CEO Rating Score.
Anonymously Ask GlaxoSmithKline Any Question
Are You an Employee at GlaxoSmithKline?
Anonymously Rate Your Experience & Make Work BetterSee other culture dimensions at GlaxoSmithKline
×